Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

B-type Chronic Lymphocytic Leukemia (B-CLL) Subgroups: Maturation Stage and Gene Expression

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by Northwell Health
Sponsor:
Information provided by (Responsible Party):
Nicholas Chiorazzi, Northwell Health
ClinicalTrials.gov Identifier:
NCT01030913
First received: December 10, 2009
Last updated: November 2, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2019
  Estimated Primary Completion Date: January 2019 (Final data collection date for primary outcome measure)